# Maintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON)

> **NCT01325896** · PHASE2 · UNKNOWN · sponsor: **Fundación de Investigación Biomédica - Hospital Universitario de La Princesa** · enrollment: 33 (estimated)

## Conditions studied

- Multiple Mieloma

## Interventions

- **DRUG:** PEG-Intron sc injection

## Key facts

- **NCT ID:** NCT01325896
- **Lead sponsor:** Fundación de Investigación Biomédica - Hospital Universitario de La Princesa
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-09
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2011-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01325896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01325896, "Maintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01325896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*